Security Snapshot

Sunshine Biopharma Inc. - Common Units, $ 0.001 par value (SBFM) Institutional Ownership

CUSIP: 867781403

13F Institutional Holders and Ownership History from Q1 2022 to Q2 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
17,152,659
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • SBFM - Sunshine Biopharma Inc. - Common Units, $ 0.001 par value is tracked under CUSIP 867781403.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 12 to 0 between Q1 2024 and Q2 2024.
  • SEC-reported value moved from $346,155 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

867781403

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
SBFM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIGGER CAPITAL FUND L P 9.5% 1,610,000 Bigger Michael 18 May 2026
L1 Capital Global Opportunities Master Fund, Ltd. 5.8% +17% 1,000,000 +603% L1 Capital Global Opportunities Master Fund, Ltd. 18 May 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Latest
n/a
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$346,155 0
2024 Q1 5,721,431 $346,155 -$275,851 $0.06 12
2023 Q4 2,748,847 $745,736 +$390,370 $0.27 13
2023 Q3 1,308,264 $415,048 -$388,177 $0.31 9
2023 Q2 2,518,904 $1,245,503 +$1,019,124 $0.49 8
2023 Q1 376,401 $264,188 +$1,002 $0.73 10
2022 Q4 407,207 $261,605 -$24,199 $0.64 10
2022 Q3 429,065 $341,061 -$262,385 $0.77 10
2022 Q2 735,073 $800,085 -$2,673,546 $1.08 12
2022 Q1 1,468,220 $3,546,194 +$3,546,194 $2.45 12
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .